Petra Vychytilova‐Faltejskova

Author

Also Known As

P VYCHYTILOVA-FALTEJSKOVA, P. VYCHYTILOVÁ-FALTEJSKOVÁ, PETRA VYCHYTILOVA-FALTEJSKOVA, Petra Faltejskova-Vychytilova, Petra Vychytilova-Faltejskova, Petra Vychytilova‐Faltejskova, V De Petra, Vychytilova-Faltejskova P, Vychytilova-Faltejskova, Petra, Vychytilová-Faltejsková Petra

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Masaryk Memorial Cancer Institute Central European Institute of Technology Central European Institute of Technology – Masaryk University Masaryk University University Hospital Brno

About

Petra Vychytilova‐Faltejskova is an author at Masaryk Memorial Cancer Institute specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	198
2	Cell Biology	3	3	174
3	Engineering	1	1	24
4	Biomedical Engineering	1	1	24
5	Neurology	1	1	24

Petra Vychytilova‐Faltejskova

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer Nithyananda Thorenoor, Petra Vychytilova‐Faltejskova, Sonja Hombach, Oncotarget	2015	175
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer Petra Vychytilova‐Faltejskova, Lenka Radová, Milana Šachlová, Carcinogenesis	2016	163
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9 Petra Vychytilova‐Faltejskova, Jana Merhautová, Táňa Macháčková, Oncogenesis MedicineEgfr Ligand EpiregulinPathologyColorectal CancerCancer Cell Biology	2017	101
Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer Petra Vychytilova‐Faltejskova, Karolína Štítkovcová, Lenka Radová, Cancer Epidemiology Biomarkers & Prevention	2018	101
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer Martin Pichler, Cristian Rodriguez‐Aguayo, Su Youn Nam, Gut	2020	94
Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis Martin Pichler, Verena Stiegelbauer, Petra Vychytilova‐Faltejskova, Clinical Cancer Research	2016	83
miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5 Verena Stiegelbauer, Petra Vychytilova‐Faltejskova, Michael Karbiener, Clinical Cancer Research	2017	76
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab Jitka Mlčochová, Petra Vychytilova‐Faltejskova, Manuela Ferracin, Oncotarget	2015	74
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma Petra Vychytilova‐Faltejskova, Igor Kišš, Sona Klusova, Diagnostic Pathology	2015	72
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients Laura Lupini, Cristian Bassi, Jitka Mlčochová, BMC Cancer	2015	59

Page 1